Home12V • FRA
add
Veracyte Inc
Previous close
€26.20
Day range
€27.40 - €27.40
Year range
€18.90 - €44.60
Market cap
2.30B USD
Avg Volume
10.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 114.47M | 18.20% |
Operating expense | 74.04M | 6.38% |
Net income | 7.05M | 478.06% |
Net profit margin | 6.16 | 420.83% |
Earnings per share | 0.31 | 710.03% |
EBITDA | 13.41M | 880.41% |
Effective tax rate | 5.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 287.36M | 37.37% |
Total assets | 1.32B | 9.61% |
Total liabilities | 120.48M | 47.96% |
Total equity | 1.19B | — |
Shares outstanding | 78.31M | — |
Price to book | 1.72 | — |
Return on assets | 1.54% | — |
Return on capital | 1.63% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 7.05M | 478.06% |
Cash from operations | 5.36M | 159.80% |
Cash from investing | -51.82M | -1,900.49% |
Cash from financing | -6.48M | -650.46% |
Net change in cash | -52.87M | -648.81% |
Free cash flow | 3.14M | 143.11% |
About
Founded
2006
Headquarters
Website
Employees
824
